The FDA approved Emrosi (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions of ...

The FDA has approved oxycodone hydrochloride (RoxyBond) for the management of severe pain when other treatments have proved ...

Given the potential risks for drug-resistant bacteria, minocycline hydrochloride should only be used as indicated. The drug ...

Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care ...

Some North Carolinians may be eligible for compensation if they paid too much for generic prescription drugs made by Heritage ...

Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.

【导读】了解对化学扰动的转录反应是药物发现的核心，但对疾病-化合物组合进行详尽的实验筛选是不可行的。为了克服这一限制，团队在这里介绍了PRnet，这是一种扰动条件的深度生成模型，可预测对新型化学扰动的转录反应，这些扰动从未在批量和单细胞水平上进行过实 ...

Journey Medical (NASDAQ:DERM) has received FDA approval for its drug Emrosi for the treatment of rosacea. Emrosi is the brand ...

The difference between a good tablet and a bad one can be stark. Our tough independent tests weed out the models to avoid and our expert buying advice will help you choose a winner. Use the results of ...

Commonly used calcium supplement Shelcal 500 and antacid Pan D are among the four drugs flagged as spurious by the Central ...

Roxybond (oxycodone hydrochloride) immediate-release 10mg tablet for the management of pain severe enough to require an opioid analgesic.

STERLING, Va. — A Guatemalan woman was arrested at Washington Dulles International Airport on Sunday, after U.S. Customs and ...